Inventor · disambiguated record
John Hood
Also filed as: HOOD JOHN · HOOD JOHN JAMES DAVID · HOOD JR JOHN J
116 granted patents·18 pending applications·2,610 citations·filing 1991–2025
99Inventor score
Files withSAMUMED LLC98BIOSPLICE THERAPEUTICS INC11ENDEAVOR BIOMEDICINES INC6HOOD JOHN4HOOD JOHN JAMES DAVID3
Top patents by PatentIndex Score
134 records- 0199US9844536B23-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Dec 19, 2017·49 cites·37 claims
- 0299US9828372B22-(1H-indazol-3-yl)-1H-imidazo[4,5-C]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Nov 28, 2017·49 cites·36 claims
- 0399US9763951B23-(3H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Sep 19, 2017·49 cites·36 claims
- 0499US9763927B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Sep 19, 2017·49 cites·26 claims
- 0599US9586977B21H-pyrazolo[3,4-b]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Mar 7, 2017·49 cites·22 claims
- 0699US9381192B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Jul 5, 2016·49 cites·47 claims
- 0799US9233104B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Jan 12, 2016·67 cites·28 claims
- 0899US9199991B2Indazole inhibitors of the WNT signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Dec 1, 2015·70 cites·38 claims
- 0999US8987298B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Mar 24, 2015·77 cites·79 claims
- 1099US8901150B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Dec 2, 2014·77 cites·30 claims
- 1199US8703794B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Apr 22, 2014·81 cites·20 claims
- 1299US8697887B2Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitorsSAMUMED LLC·Filed 2013·Granted Apr 15, 2014·104 cites·23 claims
- 1399US8673936B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Mar 18, 2014·85 cites·28 claims
- 1499US8664241B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Mar 4, 2014·83 cites·30 claims
- 1599US8618128B11H-pyrazolo[3,4-b]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Dec 31, 2013·84 cites·30 claims
- 1699US8604052B2Indazole inhibitors of the WNT signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Dec 10, 2013·92 cites·18 claims
- 1798US10407425B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2018·Granted Sep 10, 2019·15 cites·18 claims
- 1898US9889140B23-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Feb 13, 2018·23 cites·36 claims
- 1998US9855272B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Jan 2, 2018·44 cites·17 claims
- 2098US9815854B23-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Nov 14, 2017·49 cites·37 claims
- 2198US9802916B2Indazole-3-carboxamides and their use as Wnt/beta-catenin signaling pathway inhibitorsSAMUMED LLC·Filed 2015·Granted Oct 31, 2017·52 cites·3 claims
- 2298US9745271B25-substituted indazole-3-carboxamides and preparation and use thereofSAMUMED LLC·Filed 2015·Granted Aug 29, 2017·58 cites·16 claims
- 2398US9540398B23-(1h-imidazo[4,5-C]pyridin-2-yl)-1h-pyrazolo[3,4-C]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Jan 10, 2017·33 cites·32 claims
- 2498US9221793B2Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitorsHOOD JOHN·Filed 2012·Granted Dec 29, 2015·86 cites·28 claims
- 2598US9090613B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Jul 28, 2015·84 cites·23 claims
- 2698US9067939B21H-pyrazolo[3,4-b]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Jun 30, 2015·75 cites·18 claims
- 2798US9012472B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Apr 21, 2015·73 cites·77 claims
- 2898US8883822B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Nov 11, 2014·76 cites·16 claims
- 2998US8846714B21H-pyrazolo[3,4-β]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Sep 30, 2014·82 cites·32 claims
- 3098US8822478B2Indazole inhibitors of the WNT signal pathway and therapeutic uses thereofHOOD JOHN·Filed 2012·Granted Sep 2, 2014·79 cites·65 claims
- 3198US8450340B21H-pyrazolo[3,4-b]pyridines and therapeutic uses thereofHOOD JOHN·Filed 2010·Granted May 28, 2013·132 cites·22 claims
- 3298US8252812B2Indazole inhibitors of the WNT signal pathway and therapeutic uses thereofHOOD JOHN·Filed 2010·Granted Aug 28, 2012·93 cites·24 claims
- 3397US11697649B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofBIOSPLICE THERAPEUTICS INC·Filed 2021·Granted Jul 11, 2023·3 cites·31 claims
- 3497US10947228B2Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2019·Granted Mar 16, 2021·9 cites·36 claims
- 3597US10131677B23-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridine and therapeutic uses thereofSAMUMED LLC·Filed 2017·Granted Nov 20, 2018·15 cites·32 claims
- 3696US11066388B2Indazole-3-carboxamides and their use as WNT/B-catenin signaling pathway inhibitorsBIOSPLICE THERAPEUTICS INC·Filed 2019·Granted Jul 20, 2021·8 cites·28 claims
- 3796US9994563B2Indazole inhibitors of the wnt signal pathway and therapeutic uses thereofSAMUMED LLC·Filed 2015·Granted Jun 12, 2018·7 cites·5 claims
- 3896US9795550B2Gamma-diketones for treatment and prevention of aging skin and wrinklesSAMUMED LLC·Filed 2015·Granted Oct 24, 2017·12 cites·38 claims
- 3995US12213974B2Methods of treating fibrosisENDEAVOR BIOMEDICINES INC·Filed 2024·Granted Feb 4, 2025·4 cites·26 claims
- 4095US11560378B2Treatment of osteoarthritisBIOSPLICE THERAPEUTICS INC·Filed 2020·Granted Jan 24, 2023·3 cites·8 claims
- 4195US8629176B1β- and γ-diketones and γ-hydroxyketones as WNT/ β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2013·Granted Jan 14, 2014·17 cites·14 claims
- 4294US12295954B2Methods of treating fibrosisENDEAVOR BIOMEDICINES INC·Filed 2023·Granted May 13, 2025·4 cites·13 claims
- 4394US11628167B2Method of treating fibrosisENDEAVOR BIOMEDICINES INC·Filed 2022·Granted Apr 18, 2023·8 cites·18 claims
- 4494US10434052B2Gamma-diketones for treatment and prevention of aging skin and wrinklesSAMUMED LLC·Filed 2017·Granted Oct 8, 2019·3 cites·18 claims
- 4594US9908867B23-(benzoimidazol-2-yl)-indazole inhibitors of the Wnt signaling pathway and therapeutic uses thereofSAMUMED LLC·Filed 2014·Granted Mar 6, 2018·20 cites·8 claims
- 4694US8921413B2β- and γ-diketones and γ-hydroxyketones as WNT/ β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2013·Granted Dec 30, 2014·14 cites·15 claims
- 4794US8815897B21H-pyrazolo[3,4-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2013·Granted Aug 26, 2014·82 cites·65 claims
- 4893US12447148B2Methods of improving lung functionENDEAVOR BIOMEDICINES INC·Filed 2025·Granted Oct 21, 2025·4 cites·29 claims
- 4993US9884053B2β- and γ-diketones and γ-hydroxyketones as WNT/β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2016·Granted Feb 6, 2018·7 cites·42 claims
- 5093US9303010B2β- and γ-diketones and γ-hydroxyketones as Wnt/β-catenin signaling pathway activatorsSAMUMED LLC·Filed 2014·Granted Apr 5, 2016·12 cites·11 claims
Showing the top 50 of 134 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when John Hood files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →